drugset / Trial / NCT00853073

Does Adding Bevacizumab Therapy in Glaucoma Surgery Improve the Success of Needle Bleb Revisions?

NCT00853073

Phase 2/3 Completed 63 enrolled Wills Eye
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to see if a new add on (or adjunctive) therapy used in glaucoma surgery improves the success of needle bleb revisions.

Timeline

Start
2009-02
Primary completion
2012-01
Completion
2012-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bevacizumab Monoclonal antibody 1 mg Other

Indications